fbpx

Concerned about memory loss?

Loss of memory may seem like an unavoidable part of aging, but there are things we can do to be proactive about it. Whether it’s yourself or someone you love experiencing memory loss, there are ways to get a clearer picture of its progression, and to help others at the same time. By participating in a clinical trial, those with memory loss help researchers to better understand brain changes and potential new directions. You can help reshape Alzheimer’s disease treatment.

How It Works

Starting the process only takes a few minutes

Complete The Survey

Answer eight easy questions, and we’ll let you know whether you or your loved one may be eligible to participate in the study.

Schedule An Appointment

If you or a loved one are eligible, the next step is speaking with a coordinator. Find 15 minutes that work for you, and we’ll get you connected.

Speak To A Team Member

Our dedicated team understands your situation and will listen, answer any questions, and address your concerns. We’re here to help.

Forms of Memory Loss

What is Dementia?

Dementia is a term used to describe a group of symptoms that affect social and intellectual abilities profoundly enough that it interferes with daily function.

What is Alzheimer’s Disease?

Alzheimer’s Disease develops slowly, and gradually worsens over several years. It affects most areas of the brain, including thinking, memory, judgment, language, personality, problem-solving and movement, and its progression looks different in every person living with the disease.

There are five stages associated with Alzheimer’s Disease:

Preclinical Alzheimer’s Disease

Identified only in research settings, it occurs before any symptoms become evident and can last years. Can be determined by genetic testing, biomarkers, or imaging that detects the presence of amyloid beta protein deposits in the brain, which are a signature of the disease.

Mild Cognitive Impairment Due to Alzheimer’s Disease

Marked by mild changes in thinking ability and memory, often tied to lapses in memory of recent conversations, appointments, or events, as well as misjudging how much time is required to complete a task or how many steps are needed. Mild cognitive impairment, or MCI, can also be due to causes other than Alzheimer’s Disease.

Mild Dementia Due to Alzheimer’s Disease

Diagnosis typically occurs in this stage, which includes symptoms like memory loss of recent events, asking the same question over and over, lapses in decision-making and judgment (commonly tied to financial matters), loss of motivation or becoming more withdrawn in personality, increased irritability, lacking the words to express objects or ideas, and misplacing belongings or getting lost more frequently.

Moderate Dementia Due to Alzheimer’s Disease

Confusion and forgetfulness may progress in this stage, and more help is needed in daily activities or with self-care. Individuals may confuse family members or friends with each other, lose track of the day or the season, wander off in search of more familiar surroundings, forget details of their personal history, require assistance with grooming and activities of daily living like hygiene and self-care, experience paranoia, hear or see things that are not there, become physically aggressive, or exhibit increasingly agitated behavior.

Severe Dementia Due to Alzheimer’s Disease

In this late stage, the disease has a growing impact on movement and physical capabilities, as well as decreased mental function. Individuals can no longer speak coherently, will require total assistance with activities of daily living like eating, dressing and using the bathroom, and may be unable to walk without assistance, hold one’s head up without support, and eventually be unable to control bladder and bowel functions and lose the ability to swallow.

On average, patients with Alzheimer’s Disease live between 3 and 11 years after diagnosis, and the progression can vary widely. Untreated vascular risk factors like hypertension are associated with a more rapid rate of progression of Alzheimer’s Disease.

Do these symptoms sound like you or someone you love?

Who Can Participate?

Here are the eligibility criteria participants need to meet in order to join the INmuneBio study.

  • image/svg+xml
    50 to 85 years old
  • image/svg+xml
    Experiencing memory problems or have been diagnosed with Mild Cognitive Impairment or Mild Alzheimer’s Disease
  • image/svg+xml
    Have a caregiver or partner who would be willing to act as your study partner and attend sessions with you for the duration of the study

Learn more about our participation eligibility requirements to see if you or your loved one are a good fit for this trial.

Clinical Trials Make A Difference

When you participate in a clinical study, you provide valuable information that could eventually lead to better treatment, and —with the right breakthrough— to better outcomes for people living with the disease. Take our short eight question survey to see if you or your loved one are a good fit. There is no obligation.

Participate In Innovation

Shape the Future

Help Others

Frequently Asked Questions

Still have questions? Contact us anytime at [email protected].

A BETTER PATH FORWARD

Do you still have questions?

Contact us anytime at [email protected].

Please enable JavaScript in your browser to complete this form.
Are you answering this screening on behalf of yourself or a loved one?
What is your full name?
Which location is most convenient for you?
By clicking "I agree", you understand and agree to the terms of the Privacy Policy. You understand and agree that by selecting the submit button, you give permission to share your responses with the study doctors and staff at the clinical research site that you selected, and that they may contact you to discuss the study.